Correlation Engine 2.0
Clear Search sequence regions


  • angiogenesis (1)
  • apoptosis (1)
  • cancers (4)
  • cell cycle (1)
  • cellular (1)
  • disease and (1)
  • hispidulin (9)
  • humans (1)
  • metastasis (1)
  • mice (1)
  • products (3)
  • toxic drug (1)
  • Sizes of these terms reflect their relevance to your search.

    Cancer is one of the most devastating disease and leading cause of death worldwide. The conventional anticancer drugs are monotarget, toxic, expensive and suffer from drug resistance. Development of multi-targeted drugs from natural products has emerged as a new paradigm to overcome aforementioned conventionally encountered obstacles. Hispidulin (HIS), is a biologically active natural flavone with versatile biological and pharmacological activities. The anticancer, antimutagenic, antioxidative and anti-inflammatory properties of HIS have been reported. The aim of this review is to summarize the findings of several studies over the last few decades on the anticancer activity of HIS published in various databases including PubMed, Google Scholar, and Scopus. HIS has been shown to reduce the growth of cancer cells by inducing apoptosis, arresting cell cycle, inhibiting angiogenesis, invasion and metastasis via modulating multiple signaling pathways implicated in cancer initiation and progression. Multitargeted anticancer activity of HIS remains the strongest point for developing it into potential anticancer drug. We also highlighted the natural sources, anticancer mechanism, cellular targets, and chemo-sensitizing potential of HIS. This review will provide bases for design and conduct of further pre-clinical and clinical trials to develop HIS into a lead structure for future anticancer therapy. © 2020 John Wiley & Sons Ltd.

    Citation

    Aisha Ashaq, Muhammad F Maqbool, Amara Maryam, Muhammad Khan, Hafiz A Shakir, Muhammad Irfan, Javed I Qazi, Yongming Li, Tonghui Ma. Hispidulin: A novel natural compound with therapeutic potential against human cancers. Phytotherapy research : PTR. 2021 Feb;35(2):771-789

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32945582

    View Full Text